Abstract:Abstract Background Microglia are the primary phagocytes of the central nervous system and are responsible for removing damaged myelin following demyelination. Previous investigations exploring the consequences of myelin phagocytosis on microglial activation overlooked the biochemical modifications present on myelin debris. Such modifications, including citrullination, are increased within the inflammatory environment of multiple sclerosis lesions. Methods Mouse cortical myelin isolated by ultracentrifugation was citrullinated ex vivo by incubation with the calcium-dependent peptidyl arginine deiminase PAD2. Demyelination was induced by 6 weeks of cuprizone (0.3%) treatment and spontaneous repair was initiated by reversion to normal chow. Citrullinated or unmodified myelin was injected into the primary motor cortex above the cingulum bundle at the time of reversion to normal chow and the consequent impact on remyelination was assessed by measuring the surface area of myelin basic protein-positive fibers in the cortex 3 weeks later. Microglial responses to myelin were characterized by measuring cytokine release, assessing flow cytometric markers of microglial activation, and RNAseq profiling of transcriptional changes. Results Citrullinated myelin induced a unique microglial response marked by increased tumor necrosis factor α (TNFα) production both in vitro and in vivo. This response was not induced by unmodified myelin. Injection of citrullinated myelin but not unmodified myelin into the cortex of cuprizone-demyelinated mice significantly inhibited spontaneous remyelination. Antibody-mediated neutralization of TNFα blocked this effect and restored remyelination to normal levels. Conclusions These findings highlight the role of post-translation modifications such as citrullination in the determination of microglial activation in response to myelin during demyelination. The inhibition of endogenous repair induced by citrullinated myelin and the reversal of this effect by neutralization of TNFα may have implications for therapeutic approaches to patients with inflammatory demyelinating disorders.

IN-VIVO KINEMATICS OF THE THREE COMPONENTS OF A TOTAL ANKLE PROSTHESIS

Cellular architecture of evolving neuroinflammatory lesions and multiple sclerosis pathology

How to Use the Cuprizone Model to Study De- and Remyelination

An Ex-Vivo Multiple Sclerosis Model of Inflammatory Demyelination Using Hyperbranched Polymer

The effects of a combination of ion channel inhibitors on pathology in a model of demyelinating disease

Isatin derivatives with activity against apoptosis-resistant cancer cells.

Pelvic lipomatosis in females.

Dynamics of reactive astrocytes fosters tissue regeneration after cuprizone-induced demyelination

IL-17A Promotes Granulocyte Infiltration, Myelin Loss, Microglia Activation, and Behavioral Deficits During Cuprizone-Induced Demyelination

A lymphocyte–microglia–astrocyte axis in chronic active multiple sclerosis

Maladaptive cortical hyperactivity upon recovery from experimental autoimmune encephalomyelitis

Differential roles of microglia and monocytes in the inflamed central nervous system.

Strategies for Virtual Enterprises using XForms and the Semantic Web

Pre-clinical and Clinical Implications of “Inside-Out” vs. “Outside-In” Paradigms in Multiple Sclerosis Etiopathogenesis

[Drug treatment of diabetes mellitus].

Sub-clinical glutamate receptor antagonist combinations prevent progressive demyelination

Activated microglia drive demyelination via CSF1R signaling

A novel combination approach to effectively reduce inflammation and neurodegeneration in multiple sclerosis models

Mild Disease Course of Experimental Autoimmune Encephalomyelitis without Pertussis Toxin: Brain Transcriptome Analysis Reveals Similar Signaling to Active Lesions in Multiple Sclerosis

Citrullinated myelin induces microglial TNFα and inhibits endogenous repair in the cuprizone model of demyelination

Stool antigen tests for the detection of Helicobacter pylori in children.